BRCA1 and ovarian carcinoma: Large genomic rearrangements (LGRs), occurring as copy number alterations (CNAs), represent a clinically relevant class of pathogenic or likely pathogenic variants (P LPVs) in <i>BRCA1/2</i> (<i>BRCA</i>) genes in ovarian cancer (OC).